Modular Medical, Inc.(MODD)

Medical - Devices · San Diego, CA

$2.66+0.36 (+15.65%)

Delayed quote: Oct 6, 2026, 12:14 PM EDT

PS Ratio: N/A

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/S ratio is N/A as of 2026-10-06T16:13:07.432Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:13:07.432Z.

Quote observation: 2026-10-06T16:06:15.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 20,377,058
TTM revenue · period ending 2026-06-30: 0

FMP input reference: 85842aa9b6cc8ebfa961f669867d571d507c26eab2d350d24b64fb3509ac0979

P/E Ratio|Gross Margin|Revenue Growth|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

MODD PS Ratio Metrics

PS RATIO

N/A

MODD Competitors' PS Ratio

MODD

Modular Medical, Inc.

Current

Market Cap

$20.38M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

QNTM

Quantum BioPharma Ltd.

vs MODD

Market Cap

$20.54M

PS Ratio

N/A

TTM Avg

252.77

3Y Avg

5169.56

5Y Avg

5169.56

ACTU

Actuate Therapeutics Inc

vs MODD

Market Cap

$20.03M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PIII

P3 Health Partners Inc.

vs MODD

Market Cap

$19.66M

PS Ratio

0.01

TTM Avg

0.02

3Y Avg

0.04

5Y Avg

0.14

NXTC

NextCure, Inc.

vs MODD

Market Cap

$19.25M

PS Ratio

N/A

TTM Avg

15.99

3Y Avg

112.90

5Y Avg

112.90

NEUP

Neuphoria Therapeutics Inc.

vs MODD

Market Cap

$18.54M

PS Ratio

15.79

TTM Avg

3.71

3Y Avg

52.88

5Y Avg

45311.56

ESLA

Estrella Immunopharma, Inc.

vs MODD

Market Cap

$18.40M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LONA

LeonaBio, Inc.

vs MODD

Market Cap

$22.48M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AYTU

Aytu BioPharma, Inc.

vs MODD

Market Cap

$22.65M

PS Ratio

0.39

TTM Avg

0.46

3Y Avg

0.28

5Y Avg

0.24

RNTX

Rein Therapeutics Inc.

vs MODD

Market Cap

$22.75M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PS RATIO	TTM	3Y	5Y
Modular Medical, Inc. (MODD)	$20.38M	N/A	N/A	N/A	N/A
Quantum BioPharma Ltd. (QNTM)vs ›	$20.54M	N/A	252.77	5169.56	5169.56
Actuate Therapeutics Inc (ACTU)vs ›	$20.03M	N/A	N/A	N/A	N/A
P3 Health Partners Inc. (PIII)vs ›	$19.66M	0.01	0.02	0.04	0.14
NextCure, Inc. (NXTC)vs ›	$19.25M	N/A	15.99	112.90	112.90
Neuphoria Therapeutics Inc. (NEUP)vs ›	$18.54M	15.79	3.71	52.88	45311.56
Estrella Immunopharma, Inc. (ESLA)vs ›	$18.40M	N/A	N/A	N/A	N/A
LeonaBio, Inc. (LONA)vs ›	$22.48M	N/A	N/A	N/A	N/A
Aytu BioPharma, Inc. (AYTU)vs ›	$22.65M	0.39	0.46	0.28	0.24
Rein Therapeutics Inc. (RNTX)vs ›	$22.75M	N/A	N/A	N/A	N/A

How this was calculated

Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.

Revenue calculation and filing references
Fiscal period	Revenue	Source
Q2 FY2026Period ended 2025-09-30	$0	Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-14
Q3 FY2026Period ended 2025-12-31	$0	Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-17
Q4 FY2026Period ended 2026-03-31	$0	Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-06-29
Q1 FY2027Period ended 2026-06-30	$0	Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-14
TTM revenue	$0

The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.

These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.

Sales Valuation

P/S Ratio

N/A

Market Cap / Trailing Twelve-Month Revenue

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio: N/A

MODD PS Ratio Metrics

MODD Competitors' PS Ratio

Sales Valuation

PS Ratio Formula & Definition

Related Metrics